✦ LIBER ✦

Hit-to-Lead Studies: The Discovery of Potent, Orally Bioavailable Thiazolopyrimidine CXCR2 Receptor Antagonists.

✍ Scribed by Andrew Baxter; Anne Cooper; Elizabeth Kinchin; Kerry Moakes; John Unitt; Alan Wallace

Publisher: John Wiley and Sons
Year: 2006
Weight: 12 KB
Volume: 37
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200621157

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of Potent and Orally Bioavaila

Discovery of Potent and Orally Bioavailable N,N′-Diarylurea Antagonists for the CXCR2 Chemokine Receptor.

✍ Qi Jin; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

Hit-to-Lead Studies: The Discovery of Po

Hit-to-Lead Studies: The Discovery of Potent Adamantane Amide P2X7 Receptor Antagonists.

✍ Andrew Baxter; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 57 KB 👁 2 views

Hit-to-Lead Studies: The Discovery of Po

Hit-to-Lead Studies: The Discovery of Potent, Orally Active, Thiophenecarboxamide IKK-2 Inhibitors.

✍ Andrew Baxter; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 20 KB 👁 2 views

The Discovery of CCR5 Receptor Antagonis

The Discovery of CCR5 Receptor Antagonists for the Treatment of HIV Infection: Hit-to-Lead Studies

✍ Duncan Armour; Marcel J. de Groot; Martin Edwards; Manos Perros; David A. Price; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views